Related Experiment Video
Updated: Mar 16, 2026

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
Aberrant sialylation causes dilated cardiomyopathy and stress-induced heart failure
Wei Deng1, Andrew R Ednie1, Jianyong Qi1,2
1Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, MDC 8, 12901 Bruce B. Downs Blvd., Tampa, FL, 33612-4799, USA.
Insights
Reduced protein sialylation, linked to dilated cardiomyopathy (DCM), impairs heart function and increases arrhythmia risk. This study introduces a novel mouse model demonstrating how altered sialylation contributes to heart failure, even under stress.
Area of Science:
- Cardiology
- Biochemistry
- Genetics
Background:
- Dilated cardiomyopathy (DCM) is a major cause of heart failure, often linked to arrhythmias, with unknown causes in most cases.
- Altered protein sialylation is observed in human DCM, but the underlying mechanisms remain unclear.
- Sialylation plays a crucial role in protein function, including cardiac ion channels and signaling pathways.
Purpose of the Study:
- To investigate the functional impact of altered protein sialylation on cardiac function and heart failure development.
- To establish and characterize a novel mouse model with a specific sialyltransferase deletion (ST3Gal4-/-) mimicking aspects of human DCM.
- To explore the relationship between reduced sialylation, cardiac calcineurin levels, and susceptibility to stress-induced heart failure.
Main Methods:
- Utilized ST3Gal4 knockout (ST3Gal4-/-) mice as a model for altered glycoprotein sialylation.
- Performed echocardiography and histology to assess cardiac structure and function in ST3Gal4-/- mice.
- Measured cardiac calcineurin expression in young ST3Gal4-/- mice.
- Subjected younger mice to transverse aortic constriction (TAC) to induce chronic stress and evaluated cardiac response.
Main Results:
- ST3Gal4-/- mice exhibited modest left ventricular dilation and thinning without fibrosis by one year of age.
- Younger ST3Gal4-/- mice showed significantly reduced cardiac calcineurin expression compared to wild-type (WT) controls.
- TAC-induced stress led to significantly reduced systolic function and ventricular dilation in ST3Gal4-/- mice, progressing to congestive heart failure within six weeks.
- WT mice successfully compensated for TAC, maintaining normal cardiac function.
Conclusions:
- A novel, sialo-dependent mouse model for DCM and heart failure (HF) has been developed.
- Clinically relevant reduction in sialylation leads to increased arrhythmogenicity and reduced cardiac calcineurin levels.
- These alterations precede cardiomyopathy and stress-induced HF, suggesting a causal link between aberrant sialylation, arrhythmia, reduced calcineurin, DCM, and HF.
Abstract:
Dilated cardiomyopathy (DCM), the third most common cause of heart failure, is often associated with arrhythmias and sudden cardiac death if not controlled. The majority of DCM is of unknown etiology. Protein sialylation is altered in human DCM, with responsible mechanisms not yet described. Here we sought to investigate the impact of clinically relevant changes in sialylation on cardiac function using a novel model for altered glycoprotein sialylation that leads to DCM and to chronic stress-induced heart failure (HF), deletion of the sialyltransferase, ST3Gal4. We previously reported that 12- to 20-week-old ST3Gal4 (-/-) mice showed aberrant cardiac voltage-gated ion channel sialylation and gating that contribute to a pro-arrhythmogenic phenotype. Here, echocardiography supported by histology revealed modest dilated and thinner-walled left ventricles without increased fibrosis in ST3Gal4 (-/-) mice starting at 1 year of age. Cardiac calcineurin expression in younger (16-20 weeks old) ST3Gal4 (-/-) hearts was significantly reduced compared to WT. Transverse aortic constriction (TAC) was used as a chronic stressor on the younger mice to determine whether the ability to compensate against a pathologic insult is compromised in the ST3Gal4 (-/-) heart, as suggested by previous reports describing the functional implications of reduced cardiac calcineurin levels. TAC'd ST3Gal4 (-/-) mice presented with significantly reduced systolic function and ventricular dilation that deteriorated into congestive HF within 6 weeks post-surgery, while constricted WT hearts remained well-adapted throughout (ejection fraction, ST3Gal4 (-/-) = 34 ± 5.2 %; WT = 53.8 ± 7.4 %; p < 0.05). Thus, a novel, sialo-dependent model for DCM/HF is described in which clinically relevant reduced sialylation results in increased arrhythmogenicity and reduced cardiac calcineurin levels that precede cardiomyopathy and TAC-induced HF, suggesting a causal link among aberrant sialylation, chronic arrhythmia, reduced calcineurin levels, DCM in the absence of a pathologic stimulus, and stress-induced HF.
More Related Videos
13:36Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface
Published on: October 20, 2023
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Rheumatic Heart Disease I: Introduction
Heart Failure II: Pathophysiology
Cardiomyopathy IV: Restrictive Cardiomyopathy